Product
Umeclidinium/vilanterol
1 clinical trial
2 indications
Indication
Chronic obstructive pulmonary diseaseIndication
Congestive Heart FailureClinical trial
Phase IV, Single-center, Double Blind, Randomized, Crossover, Placebo-controlled Study, to Investigate the Effect of Dual Bronchodilation With Umeclidinium Vilanterol on Patients With COPD, Hyperinflation and Heart Failure.Status: Recruiting, Estimated PCD: 2024-12-01